Exforge Hct (amlodipine recalls
The FDA has published 3 recalls involving Exforge Hct (amlodipine since 2013. The latest was reported on 18 Dec 2013. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 18 Dec 2013
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why exforge hct (amlodipine is recalled
Companies
By year
All exforge hct (amlodipine recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Exforge HCT (amlodipine, valsartan recalled by Novartis Pharmaceuticals | Novartis Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | Exforge HCT (amlodipine, valsartan recalled by Novartis Pharmaceuticals | Novartis Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) 5/160/25 mg recalled | Novartis Pharmaceuticals | Other | Nationwide |
Should you stop taking Exforge Hct (amlodipine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.